Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Dec;34(3):1071–1074. doi: 10.1128/iai.34.3.1071-1074.1981

Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa.

R M Berka, G L Gray, M L Vasil
PMCID: PMC350978  PMID: 6800952

Abstract

The chromogenic substrate p-nitrophenylphosphorylcholine was used to measure phospholipase C (heat-labile hemolysin) production by clinical strains of Pseudomonas aeruginosa. Analysis of strains from various types of infection showed that phospholipase C production by urinary tract isolates was significantly greater than that by lung, blood, or other isolates (e.g., wounds, etc.). The above method was also found to be effective for the isolation of several classes of phospholipase C mutants.

Full text

PDF
1073

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baine W. B., Vasil M. L., Holmes R. K. Genetic mapping of mutations in independently isolated nontoxinogenic mutants of Vibrio cholerae. Infect Immun. 1978 Jul;21(1):194–200. doi: 10.1128/iai.21.1.194-200.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carney S. A., Jones R. J. Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa. Br J Exp Pathol. 1968 Oct;49(5):395–410. [PMC free article] [PubMed] [Google Scholar]
  3. ESSELMANN M. T., LIU P. V. Lecithinase production by gramnegative bacteria. J Bacteriol. 1961 Jun;81:939–945. doi: 10.1128/jb.81.6.939-945.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Evans D. J., Jr, Evans D. G., Höhne C., Noble M. A., Haldane E. V., Lior H., Young L. S. Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol. 1981 Jan;13(1):171–178. doi: 10.1128/jcm.13.1.171-178.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gray G. L., Berka R. M., Vasil M. L. A Pseudomonas aeruginosa mutant non-derepressible for orthophosphate-regulated proteins. J Bacteriol. 1981 Aug;147(2):675–678. doi: 10.1128/jb.147.2.675-678.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Iglewski B. H., Kabat D. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2284–2288. doi: 10.1073/pnas.72.6.2284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Iglewski B. H., Sadoff J., Bjorn M. J., Maxwell E. S. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3211–3215. doi: 10.1073/pnas.75.7.3211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kreger A. S., Gray L. D. Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage. Infect Immun. 1978 Feb;19(2):630–648. doi: 10.1128/iai.19.2.630-648.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kurioka S., Liu P. V. Effect of the hemolysin of Pseudomonas aeruginosa on phosphatides and on phospholipase c activity. J Bacteriol. 1967 Feb;93(2):670–674. doi: 10.1128/jb.93.2.670-674.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kurioka S., Liu P. V. Improved assay method for phospholipase C. Appl Microbiol. 1967 May;15(3):551–555. doi: 10.1128/am.15.3.551-555.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LIU P. V. FACTORS THAT INFLUENCE TOXIGENICITY OF PSEUDOMONAS AERUGINOSA. J Bacteriol. 1964 Nov;88:1421–1427. doi: 10.1128/jb.88.5.1421-1427.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LIU P. V. Survey of hemolysin production among species of pseudomonads. J Bacteriol. 1957 Dec;74(6):718–727. doi: 10.1128/jb.74.6.718-727.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liu P. V. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo. J Infect Dis. 1966 Oct;116(4):481–489. doi: 10.1093/infdis/116.4.481. [DOI] [PubMed] [Google Scholar]
  14. Macfarlane M. G., Knight B. C. The biochemistry of bacterial toxins: The lecithinase activity of Cl. welchii toxins. Biochem J. 1941 Sep;35(8-9):884–902. doi: 10.1042/bj0350884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pavlovskis O. R., Shackelford A. H. Pseudomonas aeruginosa exotoxin in mice: localization and effect on protein synthesis. Infect Immun. 1974 Mar;9(3):540–546. doi: 10.1128/iai.9.3.540-546.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SIERRA G. Hemolytic effect of a glycolipid produced by Pseudomonas aeruginosa. Antonie Van Leeuwenhoek. 1960;26:189–192. doi: 10.1007/BF02539004. [DOI] [PubMed] [Google Scholar]
  17. Southern P. M., Jr, Mays B. B., Pierce A. K., Sanford J. P. Pulmonary clearance of Pseudomonas aeruginosa. J Lab Clin Med. 1970 Oct;76(4):548–559. [PubMed] [Google Scholar]
  18. Stinson M. W., Hayden C. Secretion of phospholipase C by Pseudomonas aeruginosa. Infect Immun. 1979 Aug;25(2):558–564. doi: 10.1128/iai.25.2.558-564.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES